Federal Register / Vol. 87, No. 12 / Wednesday, January 19, 2022 / Notices 2767 

DEPARTMENT OF COMMERCE 

National Oceanic and Atmospheric 

Administration 

[RTID 0648–XB723] 

Fisheries of the South Atlantic; South 

Atlantic Fishery Management Council; 

Public Meetings 

AGENCY: National Marine Fisheries 

Service (NMFS), National Oceanic and 

Atmospheric Administration (NOAA), 

Commerce. 

ACTION: Notice of seminar series 

presentation. 

SUMMARY: The South Atlantic Fishery 

Management Council (Council) will host 

a presentation on working waterfront 

infrastructure in Georgia via webinar. 

DATES: The webinar presentation will be 

held on Tuesday, February 8, 2022, from 

1 p.m. until 2:30 p.m. 

ADDRESSES: 

Meeting address: The presentation 

will be provided via webinar. The 

webinar is open to members of the 

public. Information, including a link to 

webinar registration will be posted on 

the Council’s website at: https://

safmc.net/safmc-meetings/othermeetings/ as it becomes available. 

Council address: South Atlantic 

Fishery Management Council, 4055 

Faber Place Drive, Suite 201, N 

Charleston, SC 29405. 

FOR FURTHER INFORMATION CONTACT: Kim 

Iverson, Public Information Officer, 

SAFMC; phone: (843) 302–8439 or toll 

free: (866) SAFMC–10; fax: (843) 769– 

4520; email: kim.iverson@safmc.net. 

SUPPLEMENTARY INFORMATION: The 

Council will host a presentation from 

Georgia Southern University on working 

waterfronts in Georgia. The presentation 

will describe available fishing 

infrastructure in Georgia and the 

industry members utilizing that 

infrastructure. Information for the 

project was collected through a census 

of historic and current industry 

infrastructure, case studies, spatial 

analysis, a survey of seafood industry 

participants, and in-depth interviews. A 

question-and-answer session will follow 

the presentation. Members of the public 

will have the opportunity to participate 

in the discussion. The presentation is 

for informational purposes only and no 

management actions will be taken. 

Special Accommodations 

The meeting is physically accessible 

to people with disabilities. Requests for 

auxiliary aids should be directed to the 

Council office (see ADDRESSES) 5 days 

prior to the meeting. 

Note: The times and sequence specified in 

this agenda are subject to change. 

Authority: 16 U.S.C. 1801 et seq. 

Dated: January 13, 2022. 

Tracey L. Thompson, 

Acting Deputy Director, Office of Sustainable 

Fisheries, National Marine Fisheries Service. 

[FR Doc. 2022–00907 Filed 1–18–22; 8:45 am] 

BILLING CODE 3510–22–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Uniform Formulary Beneficiary 

Advisory Panel; Notice of Federal 

Advisory Committee Meeting 

AGENCY: Under Secretary of Defense for 

Personnel and Readiness, Department of 

Defense (DoD). 

ACTION: Notice of Federal Advisory 

Committee meeting. 

SUMMARY: The DoD is publishing this 

notice to announce that the following 

Federal Advisory Committee meeting of 

the Uniform Formulary Beneficiary 

Advisory Panel (UFBAP) will take 

place. 

DATES: Open to the public on day 1 of 

the meeting Tuesday, January 25, 2022, 

10:00 a.m.–6:00 p.m. and on Day 2 of 

the meeting January 26, 2022, 9:00 a.m.– 

6:00 p.m. (Eastern Standard Time). 

ADDRESSES: The meeting will be held 

telephonically or via conference call. 

The phone number for the remote access 

on January 25–26, 2022 is: CONUS: 1– 

888–946–3815; OCONUS: 1–415–228– 

4881; PARTICIPANT CODE: 6978956. 

These numbers and the dial-in 

instructions will also be posted on the 

Uniform Formulary Beneficiary 

Advisory Panel website at: https://

www.health.mil/About-MHS/OASDHA/ 

Defense-Health-Agency/Operations/ 

Pharmacy-Division/BeneficiaryAdvisory-Panel. 

FOR FURTHER INFORMATION CONTACT: 

Colonel Paul J. Hoerner, USAF, 703– 

681–2890 (Voice), dha.ncr.j6.mbx.baprequests@mail.mil (Email). 

Mailing address is 7700 Arlington 

Boulevard, Suite 5101, Falls Church, VA 

22042–5101. Website: https://

www.health.mil/About-MHS/OASDHA/ 

Defense-Health-Agency/Operations/ 

Pharmacy-Division/BeneficiaryAdvisory-Panel. The most up-to-date 

changes to the meeting agenda can be 

found on the website. 

SUPPLEMENTARY INFORMATION: Due to 

circumstances beyond the control of the 

Department of Defense and the 

Designated Federal Officer, the UFBAP 

was unable to provide public 

notification required by 41 CFR 102– 

3.150(a) concerning its January 25 

through 26, 2022 meeting. Accordingly, 

the Advisory Committee Management 

Officer for the Department of Defense, 

pursuant to 41 CFR 102–3.150(b), 

waives the 15-calendar day notification 

requirement. This meeting is being held 

under the provisions of the Federal 

Advisory Committee Act (FACA) (5 

U.S.C., Appendix) and 41 CFR 102– 

3.140 and 102–3.150. The Panel will 

review and comment on 

recommendations made to the Director, 

Defense Health Agency, by the 

Pharmacy and Therapeutics Committee, 

regarding the Uniform Formulary. 

Purpose of the Meeting: The DoD is 

publishing this notice to announce that 

the following Federal Advisory 

Committee meeting of the Uniform 

Formulary Beneficiary Advisory Panel 

will take place. 

Agenda Items 

1. Day 1—January 25, 2022 

a. 10:00 a.m.–10:10 a.m. Sign In for 

UFBAP members 

b. 10:10 a.m.–10:20 a.m. Welcome and 

Opening Remarks by Col Paul J. 

Hoerner, Designated Federal Officer 

(DFO), UFBAP 

c. 10:20 a.m.–10:30 a.m. Introduction of 

UFBAP Members by Col Hoerner 

d. 10:30 a.m.–10:45 a.m. Opening 

Remarks by UFBAP Co-Chair Senior 

Chief Petty Officer (Ret) Jon R. 

Ostrowski, Non-Commissioned 

Officers Association 

e. 10:45 a.m.–11:00 a.m. Introductory 

Remarks by CDR Scott Raisor, 

Interim Chief, Formulary 

Management Branch 

2. Discussion of the February 2021 DoD 

P&T Committee Recommendations 

Scheduled Therapeutic Class Reviews 

a. 11:00 a.m.–11:30 a.m. Breast Cancer 

Agents: Cyclin Dependent Kinase 

Inhibitors (LCDR Todd Hansen) 

b. 11:30 a.m.–12:00 p.m. Pulmonary III 

Agents (Dr. Angela Allerman) 

c. 12:00 p.m.–1:00 p.m. Break for Lunch 

d. 1:00 p.m.–1:45 p.m. Newly Approved 

Drugs Review (Dr. Amy Lugo, and 

other FMB staff, including CDR 

Raisor, and MAJ Adam Davies) 

e. 1:45 p.m.–2:45 p.m. Pertinent 

Utilization Management Issues 

(MAJ Davies, and other FMB staff, 

including Dr. Allerman, and CDR 

Raisor) 

* Note that the UFBAP Discussion and 

Vote will follow each section 

f. 2:45 p.m.–3:00 p.m. Break 


jspears on DSK121TN23PROD with NOTICES1
2768 Federal Register / Vol. 87, No. 12 / Wednesday, January 19, 2022 / Notices 

3. Discussion of the May 2021 DoD P&T 

Committee Recommendations 

Scheduled Therapeutic Class Reviews 

a. 3:00 p.m.–3:30 p.m. Menopausal 

Hormone Therapy: Single Agents, 

Combination Agents, and Vaginal 

Agents (LCDR Elizabeth Hall) 

b. 3:30 p.m.–4:00 p.m. Sleep Disorders: 

Insomnia (Dr. Lugo) 

c. 4:00 p.m.–4:45 p.m. Newly Approved 

Drugs Review (Dr. Lugo, and other 

FMB staff including, LCDR Hall, 

MAJ Davies, LCDR Hansen, and Dr. 

Allerman) 

d. 4:45 p.m.–5:15 p.m. Pertinent 

Utilization Management Issues 

(MAJ Davies and other FMB staff 

including Dr. Allerman, Dr. Lugo, 

and LCDR Hall) 

e. 5:15 p.m.–5:30 p.m. Re-evaluation of 

Nonformulary generics (Dr. 

Allerman) 

* Note that the UFBAP Discussion and 

Vote will follow each section 

f. 5:30 p.m.–5:45 p.m. Closing Remarks 

by Senior Chief Petty Officer (Ret) 

Ostrowski 

g. 5:45 p.m.–6:00 p.m. Closing Remarks 

by Col Hoerner 

Agenda Items 

1. Day 2—January 26, 2022 

a. 9:00 a.m.–9:10 a.m. Sign In for 

UFBAP members 

b. 9:10 a.m.–9:15 a.m. Welcome and 

Opening Remarks by Col Hoerner 

c. 9:15 a.m.–9:30 a.m. Opening Remarks 

by Senior Chief Petty Officer (Ret) 

Ostrowski 

2. Discussion of the August 2021 DoD 

P&T Committee Recommendations 

Scheduled Therapeutic Class Reviews 

a. 9:30 a.m.–10:00 a.m. Leukemia and 

Lymphoma Agents, Burton 

Tyrosine Kinase Inhibitors LCDR 

Hansen) 

b. 10:00 a.m.–10:30 a.m. LaxativeCathartics-Stool Softeners—Bowel 

Preparations (Dr. Lugo) 

c. 10:30 a.m.–10:45 a.m. Break 

d. 10:45 a.m.–11:45 a.m. Newly 

Approved Drugs Review (Dr. Lugo 

and other FMB staff, including 

LCDR Hall, LCDR Hansen, Dr. 

Allerman, CDR Raisor, and MAJ 

Davies) 

e. 11:45 a.m.–12:45 p.m. Pertinent 

Utilization Management Issues 

(MAJ Davies and other FMB staff, 

including Dr. Lugo, and CDR 

Raisor) 

f. 12:45 p.m.–1:00 p.m. Tier Co-Payment 

Change for the Pulmonary III 

Agents (CDR Raisor) 

g. 1:00 p.m.–1:15 p.m. Brand over 

Generic Authorization and Tier 1 

Co-Payment Change for the 

Pulmonary Arterial Hypertension 

Drugs (Dr. Allerman) 

* Note that the UFBAP Discussion and 

Vote will follow each section 

h. 1:15 p.m.–2:15 p.m. Break for Lunch 

3. Discussion of the November 2021 

DoD P&T Committee Recommendations 

Scheduled Therapeutic Class Reviews 

a. 2:15 p.m.–3:00 p.m. Continuous 

Glucose Monitoring Systems— 

Therapeutic Agents (Dr. Lugo) 

b. 3:00 p.m.–3:30 p.m. Immunological 

Agents Miscellaneous— 

Subcutaneous Immunoglobulins 

(LCDR Hansen) 

c. 3:30 p.m.–4:30 p.m. Newly Approved 

Drugs Review (Dr. Lugo and other 

FMB staff including LCDR Hansen, 

LCDR Giao Phung, LCDR Hall, MAJ 

Davies and Maj Angelina Escano) 

d. 4:30 p.m.–4:45 p.m. Break 

e. 4:45 p.m.–5:45 p.m. Pertinent 

Utilization Management Issues 

(MAJ Davies) 

*Note that the UFBAP Discussion and 

Vote will follow each section 

f. 5:45 p.m.–5:55 p.m. Closing Remarks 

by Senior Chief Petty Officer (Ret) 

Ostrowski 

g. 5:55 p.m.–6:00 p.m. Closing Remarks 

by Col Hoerner 

Meeting Accessibility: Pursuant to 

section 10(a)(1) of the FACA and 41 CFR 

102–3.140 through 102–3.165, and 

subject to the availability of phone lines, 

this meeting is open to the public. 

Telephone lines are limited and 

available to the first 220 people dialing 

in. There will be 220 line total: 200 

domestic and 20 international, 

including leader lines. 

Written Statements: Pursuant to 41 

CFR 102–3.10, and section 10(a)(3) of 

FACA, interested persons or 

organizations may submit written 

statements to the Uniform Formulary 

Beneficiary Advisory Panel about its 

mission and/or the agenda to be 

addressed in this public meeting. 

Written statements should be submitted 

to the Uniform Formulary Beneficiary 

Advisory Panel’s Designated Federal 

Officer (DFO). The DFO’s contact 

information can be found in the FOR

FURTHER INFORMATION CONTACT section of 

this notice. Written comments or 

statements must be received by the 

Uniform Formulary Beneficiary 

Advisory Panel’s DFO at least two (2) 

calendar days prior to the meeting so 

they may be made available to the 

Uniform Formulary Beneficiary 

Advisory Panel for its consideration 

prior to the meeting. The DFO will 

review all submitted written statements 

and provide copies to all Uniform 

Formulary Beneficiary Advisory Panel 

members. 

Dated: January 12, 2022. 

Aaron T. Siegel, 

Alternate OSD Federal Register, Liaison 

Officer, Department of Defense. 

[FR Doc. 2022–00887 Filed 1–18–22; 8:45 am] 

BILLING CODE 5001–06–P 

DEPARTMENT OF EDUCATION 

Request for Nominations: National 

Committee on Foreign Medical 

Education and Accreditation 

(NCFMEA) 

AGENCY: Department of Education, 

National Committee on Foreign Medical 

Education and Accreditation 

(NCFMEA). 

ACTION: Request for nominations for 

appointment to serve on the National 

Committee on Foreign Medical 

Education and Accreditation 

(NCFMEA). 

SUMMARY: Secretary of Education, 

Miguel A. Cardona, Ed.D., is seeking 

nomination(s) of medical experts for 

appointment to fill six vacant positions 

for service as a member of the National 

Committee on Foreign Medical 

Education and Accreditation 

(NCFMEA). 

DATES: Nominations must be received 

no later than Friday, February 18, 2022. 

SUPPLEMENTARY INFORMATION: 

NCFMEA’s Statutory Authority and 

Function: The NCFMEA is authorized 

per section 102 of the Higher Education 

Act of 1965, as amended. The Secretary 

of Education is required by the Higher 

Education Act, as amended, to establish 

a panel of medical experts who shall: 

Evaluate the standards of accreditation 

applied to foreign medical schools; and 

determine the comparability of those 

standards to standards for accreditation 

applied to United States medical 

schools. The NCFMEA shall be 

comprised of 11 voting members each 

appointed for a term of service as 

determined by the Secretary of 

Education. Due consideration shall be 

given to the appointment of individuals 

who are broadly knowledgeable about 

foreign medical education and 

accreditation and respected in the 

educational community. Per the 

authorizing legislation for the 

Committee, one currently serving 

member of the NCFMEA, is a medical 

student enrolled in an accredited 

medical school at the time of 

appointment by the Secretary of 

Education. 


jspears on DSK121TN23PROD with NOTICES1